Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose Kappaproct added to corticosteroids for brain tumor-related edema
2009-010756-10Phase 2Terminated
- Sponsor
- InDex Pharmaceuticals
- Start
- Mar 2009
- Modality
- Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, MicroRNA (miRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of cobitolimod in cerebral edema, glioma, meningioma and 1 more, sponsored by InDex Pharmaceuticals. Started Mar 2009; status: terminated.
02
Drugs
cobitolimod
03
Conditions
cerebral edemagliomameningiomabrain metastases
Beyond the preview
Go deeper on 2009-010756-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010756-10.